T. Clark Brelje, Ph.D.
University of Minnesota
Department of Genetics, Cell Biology and Development
6-160 Jackson Hall
321 Church St SE
Minneapolis, MN 55455
Robert L. Sorenson, Ph.D.
University of Minnesota
Department of Genetics, Cell Biology and Development
6-160 Jackson Hall
321 Church St SE
Minneapolis, MN 55455
Any view of a slide can be saved for later viewing in different ways.
Clipboard
The address of this view has been copied to your clipboard. This link can be pasted in any other program.
Bookmark
A bookmark link can be created using the bookmark function (Ctrl-D for Windows or Cmd-D for Mac) of your browser. Choose a name for the bookmark and select the folder in which you want it saved.
Eosinophils develop from the multipotential myeloid stem cell (CFU-GEMM) which differentiates into eosinophilic progenitor cells (CFU-Eo).
Eosinophilic myeloblasts are produced directly from progenitor cells (CFU-Eo) under the influence of cytokines. The eosinophilic myeloblast matures into an eosinophilic promyelocyte. These cells cannot be distinguished from cells at the same stage in other granulocyte lineages. (See MH034B Neutrophil Development for these earlier stages.)
Eosinophilic myelocyte is the first recognizable precursor of eosinophils.
Large cells (18 to 20 µm diameter)
Round, oval, or indented nucleus (50% of cell) with a coarser, granular pattern of chromatin
Cytoplasm is pale blue
Very eosinophilic, specific granules begin to accumulate
Mature eosinophils are released from bone marrow into the peripheral circulation. They circulate in the blood 8 to 16 hrs. Their tissue life span is only 2 to 5 days.